Page 7 - Astrazeneca

'USFDA study shows Evusheld retains neutralising activity against Omicron'

The study was done independently by investigators at the US Food and Drug Administration (USFDA), Center for Biologics Evaluation and Research.

Billionaire Poonawalla family pledges $66 mn to Oxford for research campus

The pledge builds on the collaboration between Oxford University, AstraZeneca and SII, the world's largest maker of vaccines

Two doses of Covid vax induce lower antibody levels against Omicron: Study

Two doses of Pfizer AstraZeneca Covid vaccines generate lower levels of antibodies against the Omicron variant of coronavirus.

AstraZeneca in touch with Indian authorities for approval to Covid drug

The company said it has initiated engagements with Indian health authorities regarding its Covid prevention drug for people with weakened immune system

US FDA okays AstraZeneca's Covid antibody cocktail for immunocompromised

The US Food and Drug Administration (FDA) has granted emergency use authorisation to AstraZeneca's monoclonal antibody treatment for Covid-19 among people with weakened immune systems.

World's best-performing IPO in 2021 is a Korean bioscience firm

South Korean biopharmaceutical firm SK Bioscience's IPO raised $1.3 billion for the firm, which is a local Covid-19 vaccine-production partner with AstraZeneca Plc.

Next pandemic could be more lethal than Covid: AstraZeneca vaccine maker

Future pandemics could be even more lethal than Covid so the lessons learned from the pandemic must not be squandered, one of the creators of the Oxford-AstraZeneca vaccine said.

AstraZeneca blocks Advent's $7.6-bn buyout of Swedish Orphan Biovitrum

The UK drugmaker's opposition meant the offer fell short of the 90 per cent threshold needed for approval

Booster dose of six Covid vaccines safe, increases immunity: Lancet study

Six different COVID-19 boosters are safe and elicit strong immune response in people who have previously received a two-dose course of AstraZeneca or Pfizer vaccines.

Delta variant may have increased ability to evade vaccine immunity: Study

Vaccines are effective in decreasing hospitalization and deaths from Covid-19 infection but the emergence of viral variants of concern may diminish their efficacy, according to a recent study.

LIVE: Two SA returnees test Covid positive in Bengaluru; Omicron reaches UK

Two linked cases of the new Omicron coronavirus variant have been detected in Britain connected to travel to southern Africa, health minister Sajid Javid said on Saturday

AstraZeneca examining impact of new Covid-19 variant on vaccine

The company has also developed an antibody cocktail which can be used both to prevent and to treat Covid-19

SII resumes exports to COVAX, produces 1.25 bn Covishield doses this year

The first batches of Covishield left the SII manufacturing facility in Pune earlier today, for distribution to low- and middle-income countries

AstraZeneca chief credits Oxford vaccine with UK's Covid-19 fight

Soriot was speaking as his company unveiled a major state-of-the-art research and development facility in Cambridge

Covid-19: AstraZeneca opens research centre as UK builds science hub

Prince Charles will be on hand Tuesday when pharmaceutical company AstraZeneca opens a 1 billion-pound research centre near the University of Cambridge

AstraZeneca Covid drug cocktail gives 83% protection over 6 months: Study

The treatment is given in one go, as two sequential shots in the arm

AstraZeneca set for 'modest' profit from Covid-19 vaccine

The Oxford/AstraZeneca vaccine has until now been sold on a not-for-profit basis

AstraZeneca to book modest profit from coronavirus vaccine

British-Swedish pharmaceutical company AstraZeneca said Friday that it will start to book a modest profit from its coronavirus vaccine as it moves away from the nonprofit model

AstraZeneca Pharma India Q2 net profit declines 55% to Rs 12 crore

The drug firm on Tuesday reported a 54.65 per cent decline in its net profit

Pfizer, Astra shots generate more antibodies than natural infection: Study

People who receive the Pfizer or AstraZeneca COVID-19 vaccine have antibody levels significantly higher than those infected with the SARS-CoV-2 virus, according to a study